Subscribe to Email Alerts
Menu
About Us
About INOVIQ
Market Opportunity
Board
The Team
Advisors
Partners
Distributors
Compliance
Careers
Technology
Our Science
NETs Biomarker Capture Platform
SubB2M Pan-Cancer Probe
BARD1 Biomarker Technology
hTERT ICC Assay
Intellectual Property
Publications
Business Development
Products
Our Products
hTERT ICC Test
EXO-NET® (RUO)
Pipeline
Development Pipeline
Investors
Investor Overview
ASX Announcements
Annual & Financial Reports
Presentations
Share Price Information
INOVIQ Fact Sheet
Corporate Governance
Shareholder Services
FAQ
Analyst Reports
Media
INOVIQ in the News
Contact
Contact Us
Subscribe to Email Alerts
ASX Announcements
Heading &
Sub-heading can be edited through HQI
Investors
>
ASX Announcements
Investor Overview
ASX Announcements
Annual & Financial Reports
Presentations
Share Price Information
INOVIQ Fact Sheet
Corporate Governance
Shareholder Services
FAQ
Analyst Reports
ASX Announcements
Filter by Year:
2022
2021
2020
2019
2018
2017
2016
3-Oct-2022
Notification of cessation of securities - IIQ
3-Oct-2022
Notice required under listing rule 3.13.1
28-Sep-2022
2022 Annual Report and update on results
30-Aug-2022
Appendix 4E and Preliminary Financial Report
9-Aug-2022
IIQ Investor Presentation
4-Aug-2022
INOVIQ Investor Briefing Invitation - June 2022 Quarter
27-Jul-2022
IIQ Appendix 4C & Quarterly Activities Report - June 2022
26-Jul-2022
Positive SubB2M IHC Results for Melanoma
22-Jul-2022
hTERT US Patent Granted
21-Jul-2022
INOVIQ Engages Sales Team to Accelerate EXO-NET Roll-out
1
2
3
4
Next
